We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

19 hedge funds and large institutions have $1.75M invested in Capricor Therapeutics in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more funds holding

Funds holding: 18 → 19 (+1)

7% less capital invested

Capital invested by funds: $1.89M → $1.75M (-$137K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Brown Advisory
Brown Advisory
Maryland
+$172K
2
AA
Apriem Advisors
California
+$172K
3
SM
Sabby Management
Florida
+$39.8K
4
Bank of America
Bank of America
North Carolina
+$1.21K

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$48K
2
Morgan Stanley
Morgan Stanley
New York
-$34.8K
3
Goldman Sachs
Goldman Sachs
New York
-$11.6K
4
Walleye Trading
Walleye Trading
New York
-$10K
5
TRCT
Tower Research Capital (TRC)
New York
-$2.47K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$513K +$39.8K +1,642 +9%
CBA
2
Coastal Bridge Advisors
Connecticut
$304K – – –
Goldman Sachs
3
Goldman Sachs
New York
$274K -$11.6K -478 -4%
Brown Advisory
4
Brown Advisory
Maryland
$181K +$172K +7,107 New
AA
5
Apriem Advisors
California
$180K +$172K +7,096 New
Morgan Stanley
6
Morgan Stanley
New York
$106K -$34.8K -1,434 -26%
Vanguard Group
7
Vanguard Group
Pennsylvania
$56K – – –
Millennium Management
8
Millennium Management
New York
$47K – – –
BFA
9
BlackRock Fund Advisors
California
$41K -$2.16K -89 -5%
HIIFS
10
Harel Insurance Investments & Financial Services
Israel
$18K – – –
PA
11
Perceptive Advisors
New York
$10K – – –
CFN
12
Cordasco Financial Network
Florida
$8K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$4K -$2.47K -102 -41%
BA
14
BlackRock Advisors
Delaware
$4K – – –
BIM
15
BlackRock Investment Management
Delaware
$1K – – –
Bank of America
16
Bank of America
North Carolina
$1K +$1.21K +50 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$111 – – –
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
– -$48K -1,570 Closed
Walleye Trading
19
Walleye Trading
New York
– -$10K -330 Closed

CAPR Hedge Fund Activity: Q1 2016 in Review

19 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q1 2016, worth a combined $1.75M — down 7.3% from $1.89M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CAPR positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Brown Advisory, opening a new position worth an estimated $172K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $48K sold.

  • 19 institutional investors held Capricor Therapeutics (CAPR) as of Q1 2016, up from 18 in Q4 2015.
  • Funds reported $1.75M of Capricor Therapeutics stock for Q1 2016, down 7.3% quarter-over-quarter.
  • 3 funds opened new Capricor Therapeutics positions in Q1 2016 and 2 closed out, a net change of +1 holder.
  • The largest Capricor Therapeutics buyer in Q1 2016 was Brown Advisory, an estimated $172K added.
  • The largest Capricor Therapeutics seller in Q1 2016 was Susquehanna International Group, an estimated $48K sold.

Based on aggregated 13F filings for Q1 2016.